DeepMed Research

THOMAS JEFFERSON UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1824-01-01

Employees: 10K

Market Cap: -

Website: http://www.jefferson.edu

Clinical Trials

TEE 3D RV Assessment for SAVR, Mini AVR, and TAVR

Recruiting

Conditions: Right Ventricular Dysfunction

Interventions: Diagnostic Test: 3D TEE RVEF

First Posted Date: 2023-04-07

Last Posted Date: 2024-11-22

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 78

Registration Number: NCT05804240

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Postoperative Gastric Point of Care Ultrasound (G-POCUS) in Abdominal Surgery

Not Applicable

Recruiting

Conditions: Ileus Postoperative
Postoperative Nausea and Vomiting

Interventions: Diagnostic Test: gastric point of care ultrasound

First Posted Date: 2023-04-03

Last Posted Date: 2023-04-07

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 128

Registration Number: NCT05796063

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial

Not Applicable

Recruiting

Conditions: Lung Carcinoma
Esophageal Carcinoma

Interventions: Other: Fludeoxyglucose F-18
Procedure: Positron Emission Tomography
Procedure: Computed Tomography
Other: Questionnaire Administration

First Posted Date: 2023-03-20

Last Posted Date: 2024-03-05

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 20

Registration Number: NCT05775939

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Immunoregulatory Effect of Microparticle Delivered STING Agonist in the Control of Experimental Autoimmune Encephalomyelitis (EAE) and Multiple Sclerosis (MS)

Recruiting

Conditions: Relapse Remitting Multiple Sclerosis

First Posted Date: 2023-01-31

Last Posted Date: 2023-01-31

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 40

Registration Number: NCT05705986

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Improving Patient Experience: BMBA

Not Applicable

Completed

Conditions: Bone Marrow Cancer
Leukemia
Lymphoma
Multiple Myeloma
Hematologic Cancer

Interventions: Other: Virtual reality
Other: Environmental changes

First Posted Date: 2023-01-19

Last Posted Date: 2025-04-24

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 60

Registration Number: NCT05690230

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer

Phase 2

Suspended

Conditions: Stage IIIB Prostate Cancer AJCC v8
Stage IIIC Prostate Cancer AJCC v8
Prostate Adenocarcinoma

Interventions: Procedure: MRI-guided Intensity-Modulated Radiation Therapy
Drug: Antiandrogen Therapy
Procedure: PSMA PET Scan
Procedure: Computed Tomography
Procedure: Magnetic Resonance Imaging
Procedure: Bone Scan
Procedure: Biospecimen Collection
Other: Quality-of-Life Assessment

First Posted Date: 2023-01-09

Last Posted Date: 2024-08-28

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 88

Registration Number: NCT05676463

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Wearable Electrical Stimulation on the Back to Modulate Spinal Cord Activity

Not Applicable

Active, not recruiting

Conditions: Spinal Cord Diseases
Spinal Cord Injuries

Interventions: Device: RISES-T System
Other: Occupational/Physical Therapy

First Posted Date: 2023-01-03

Last Posted Date: 2025-04-11

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 4

Registration Number: NCT05669508

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

"Platelet Rich Plasma for the Management of Post-Viral Olfactory Dysfunction.

Not Applicable

Conditions: Olfaction Disorders
Olfactory Disorder

Interventions: Other: Platelet rich plasma
Other: Saline

First Posted Date: 2022-12-27

Last Posted Date: 2022-12-27

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 120

Registration Number: NCT05666492

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Palbociclib or Tazemetostat in Combination With CPX-351 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Phase 1

Recruiting

Conditions: Recurrent Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia

Interventions: Drug: Liposome-encapsulated Daunorubicin-Cytarabine
Drug: Tazemetostat
Procedure: Bone Marrow Aspiration and Biopsy
Procedure: Biospecimen Collection
Drug: Palbociclib

First Posted Date: 2022-11-25

Last Posted Date: 2024-01-05

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 24

Registration Number: NCT05627232

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network

Recruiting

Conditions: Stage IV Prostate Cancer AJCC v8
Metastatic Prostate Carcinoma
Stage IIIB Prostate Cancer AJCC v8
Stage IIIC Prostate Cancer AJCC v8

Interventions: Behavioral: Training and Education
Other: Educational Intervention
Procedure: Discussion

First Posted Date: 2022-11-25

Last Posted Date: 2025-05-20

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 30

Registration Number: NCT05627219

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy